Papers of the Week

< BACK TO ARCHIVE

DATE PUBLISHED:
2020 Feb 03

JOURNAL:
J Am Acad Dermatol

PUBMED:
http://www.ncbi.nlm.nih.gov/pubmed/32029304?dopt=Abstract

Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study.

Authors

Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study.

Nakagawa H, Nemoto O, Igarashi A, Saeki H, Kaino H, Nagata T

J Am Acad Dermatol. 2020 Feb 03.

PMID: 32029304.

Abstract

Previous studies showed the potential effectiveness of delgocitinib ointment, a novel topical Janus kinase inhibitor, in atopic dermatitis (AD).

Read This Paper